NP / PA
Clemons, Kevin
Clemons, Kevin was paid $36K by Medicaid between Aug 2018 and Oct 2019, across 14 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoCLEMONS, KEVIN
MURFREESBORO, TN 37129
MURFREESBORO, TN 37129
33aNPI1528194867assigned 02/23/2007
33bProvider typePhysician Assistant
28Total paid$36K
24GClaims2,836
24DCodes billed14
24AFirst – last monthAug 2018 – Oct 2019
Compared with peers
Next to other Physician Assistant providers in Tennessee
Rank by total paid#103 of 200
Median peer was paid$36K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 782 | $12K | |
| 2019 | 2,054 | $24K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 511 | 444 | $9K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 15% | 554 | 476 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14% | 316 | 274 | $5K |
| 96160 | 10% | 356 | 321 | $4K | |
| 96138 | 9.8% | 220 | 196 | $3K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 9.5% | 193 | 172 | $3K |
| 96136 | 7.4% | 161 | 145 | $3K | |
| 96120 | 4.9% | 130 | 99 | $2K | |
| 96103 | 2.7% | 95 | 73 | $949.74 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 30 | 28 | $215.10 |
| 81002 | <1% | 143 | 118 | $176.58 | |
| 81003 | 0% | 68 | 63 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.